Safeway Pharmacy #2097 | |
4747 E Greenway Rd, Phoenix, Arizona 85032 | |
(602) 282-1974 |
Name | Safeway Pharmacy #2097 |
---|---|
Organization Name | Safeway Inc |
Location | 4747 E Greenway Rd, Phoenix, Arizona 85032 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (602) 282-1974 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Clot-busting drugs may be safe for patients who wake up experiencing stroke symptoms, according to preliminary research presented at the American Stroke Association's International Stroke Conference 2012.
A study conducted at the University of Chicago, USA, has recently revealed that downregulation of an endothelial transcription factor, Kruppel-like factor 2, by SARS-CoV-2 is responsible for ARDS frequently observed in critically ill COVID-19 patients.
New research from North Carolina State University and the National Institute of Environmental Health Sciences (NIEHS) shows significant reproductive health effects in rats that have been exposed to bisphenol-A (BPA) at levels equivalent to or below the dose that has been thought not to produce any adverse effects.
Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital. Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care.
› Verified 9 days ago
NPI Number | 1184660946 |
Organization Name | SAFEWAY INC |
Doing Business As | SAFEWAY PHARMACY #2097 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 4747 E Greenway Rd, Phoenix, AZ 85032 |
Phone Number | 602-282-1974 |
News Archive
Clot-busting drugs may be safe for patients who wake up experiencing stroke symptoms, according to preliminary research presented at the American Stroke Association's International Stroke Conference 2012.
A study conducted at the University of Chicago, USA, has recently revealed that downregulation of an endothelial transcription factor, Kruppel-like factor 2, by SARS-CoV-2 is responsible for ARDS frequently observed in critically ill COVID-19 patients.
New research from North Carolina State University and the National Institute of Environmental Health Sciences (NIEHS) shows significant reproductive health effects in rats that have been exposed to bisphenol-A (BPA) at levels equivalent to or below the dose that has been thought not to produce any adverse effects.
Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital. Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care.
› Verified 9 days ago
News Archive
Clot-busting drugs may be safe for patients who wake up experiencing stroke symptoms, according to preliminary research presented at the American Stroke Association's International Stroke Conference 2012.
A study conducted at the University of Chicago, USA, has recently revealed that downregulation of an endothelial transcription factor, Kruppel-like factor 2, by SARS-CoV-2 is responsible for ARDS frequently observed in critically ill COVID-19 patients.
New research from North Carolina State University and the National Institute of Environmental Health Sciences (NIEHS) shows significant reproductive health effects in rats that have been exposed to bisphenol-A (BPA) at levels equivalent to or below the dose that has been thought not to produce any adverse effects.
Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital. Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care.
› Verified 9 days ago
Cvs Pharmacy #03129 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1002 E Mcdowell Rd, Phoenix, Arizona 85006 Phone: (602) 258-7051 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4601e. Hilton Ave, Phoenix, Arizona 85034 Phone: (480) 446-9010 | |
Preferred Homecare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4602 E. Hammond Lane, Phoenix, Arizona 85034 Phone: (480) 993-2097 | |
Cvs Pharmacy 03625 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8245 W Thomas Rd, Phoenix, Arizona 85033 Phone: (623) 849-2439 | |
Northland Aac Type: Medicare Supplier Location: 34406 North 27th Drive, Phoenix, Arizona 85085 Phone: (877) 893-5305 |